Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus-Reference-Cited by-同舟云学术

Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus

Published:2018-01-03 Issue:8 Volume:217 Page:1289-1297
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Reid Michael¹,Ma Yifei¹,Scherzer Rebecca¹²,Price Jennifer C¹,French Audrey L³,Huhn Gregory D³,Plankey Michael W⁴,Peters Marion¹,Grunfeld Carl¹²,Tien Phyllis C¹²

Affiliation:

1. Department of Medicine, University of California–San Francisco, California

2. Medical Service, Department of Veteran Affairs Medical Center, San Francisco, California

3. Department of Medicine, Stroger Hospital and Rush University, Chicago, Illinois

4. Department of Medicine, Georgetown University Medical Center, Washington, D.C

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/8/1289/25090564/jix688.pdf

Reference29 articles.

1. Plasma levels of soluble CD14 independently predict mortality in HIV infection;Sandler;J Infect Dis,2011

2. Gut microbiome alterations in patients with stage 4 hepatitis C;Aly;Gut Pathog,2016

3. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection;Sandler;Gastroenterology,2011

4. Microbial translocation is a cause of systemic immune activation in chronic HIV infection;Brenchley;Nat Med,2006

5. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract;Brenchley;J Exp Med,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbial Translocation and Gut Damage Are Associated With an Elevated Fast Score in Women Living With and Without HIV;Open Forum Infectious Diseases;2024-03-30

2. The human microbiome and gut–liver axis in people living with HIV;Current HIV/AIDS Reports;2023-05-02

3. Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients;Egyptian Liver Journal;2023-04-29

4. Effect of HCV treatment with DAAs on serum Intestinal Fatty Acid Binding Protein (I-FABP) as a marker of intestinal permeability in HCV/ HIV co- infected patients;2022-08-03

5. Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy;JCI Insight;2022-07-08